CollPlant Biotechnologies Ltd. (CPT)

Overview

CollPlant Biotechnologies Ltd. is a pioneering company operating within the fields of regenerative and aesthetic medicine, with a strategic focus on the development of innovative solutions through three-dimensional (3D) bioprinting of tissues and organs. The company extends its presence across major markets including the United States, Canada, Israel, and Europe, enhancing its influence in the global healthcare landscape. The cornerstone of CollPlant's technological advancements is its proprietary plant-based genetic engineering technology utilized for the production of recombinant type I human collagen, which forms the basis of its diverse product portfolio. Initially established in 2004 and formerly known as CollPlant Holdings Ltd., the company underwent a rebranding to CollPlant Biotechnologies Ltd. in June 2019, thereby signifying a strategic realignment with its core operations and future aspirations. Its headquarters are located in Rehovot, Israel, positioning it within one of the leading centers for biotechnological research and development.

Products and Services

• BioInks for 3D Printing of Tissues and Organs: At the heart of CollPlant's offering is its BioInks, designed for the 3D printing of tissues and organs. This product enables the creation of complex biological structures, promising significant advancements in regenerative medicine and organ transplantation.
• Dermal Filler and Soft Tissue Fillers: To cater to the aesthetic medicine market, CollPlant has developed dermal filler and soft tissue fillers aimed at treating wrinkles and enhancing skin rejuvenation, tapping into the growing demand for non-invasive cosmetic procedures.
• 3D Bioprinted Breast Implants: A pioneering effort towards regenerative aesthetics, these implants are focused on the regeneration of breast tissue, offering an innovative solution for breast reconstruction and augmentation.
• Injectable Implants for Breast Tissue Regeneration: Complementing the breast implants, these injectable solutions promote the natural regeneration of breast tissue, proposing an alternative to traditional breast augmentation techniques.
• 3D Bioprinted Regenerative Soft Tissue Matrix: This product represents another application of CollPlant's 3D bioprinting technology, aimed at soft tissue repair and regeneration, showcasing the versatility of their bioprinting capabilities.
• VergenixSTR Soft Tissue Repair Matrix: Specifically designed for the treatment of tendinopathy, VergenixSTR is a soft tissue repair matrix that demonstrates CollPlant’s commitment to addressing a range of soft tissue injuries and conditions.
• VergenixFG Advanced Wound Care Product: Targeting a critical need in healthcare, VergenixFG is used for the treatment of deep surgical incisions and wounds, including those deriving from diabetes, venous and pressure ulcers, burns, bedsores, and other chronic wounds, providing an effective solution for advanced wound care management.